Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration.

about

Pharmacokinetics of dextromethorphan and its metabolites in horses following a single oral administration.

Item

http://www.wikidata.org/entity/Q39435571

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Pharmacokinetics of dextrometh ...... a single oral administration.

@en

Pharmacokinetics of dextrometh ...... a single oral administration.

@nl

type

Item

label

Pharmacokinetics of dextrometh ...... a single oral administration.

@en

Pharmacokinetics of dextrometh ...... a single oral administration.

@nl

prefLabel

Pharmacokinetics of dextrometh ...... a single oral administration.

@en

Pharmacokinetics of dextrometh ...... a single oral administration.

@nl

P1476

Pharmacokinetics of dextrometh ...... a single oral administration.

@en

P2093

Carley R Corado

http://www.w3.org/2001/XMLSchema#string

Daniel S McKemie

http://www.w3.org/2001/XMLSchema#string

Heather K Knych

http://www.w3.org/2001/XMLSchema#string

P2860

The role of dextromethorphan in pain control.

The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.

Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition.

A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia.

Substrate specificity, inhibitors and regulation of human cytochrome P450 2D6 and implications in drug development.

Evidence for polymorphism in the cytochrome P450 2D50 gene in horses.

Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.

Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver.

Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan.

The effect of the NMDA receptor blocker, dextromethorphan, on cribbing in horses.

P304

880-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DTA.2060

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27580591

http://www.w3.org/2001/XMLSchema#string